Q3 2011 8K Special News Release
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 14, 2011
(Exact name of registrant as specified in its charter)
(State or Other Jurisdiction
(Commission File Number)
101 Innovation Drive, San Jose, California
(Address of principal executive offices)
Registrant's telephone number, including area code: (408) 544-7000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 14, 2011, Altera Corporation (the “Company”) announced the election of Elisha W. Finney to serve as a new member of the Company's board of directors and audit committee, effective September 14, 2011. Ms. Finney is currently Senior Vice President, Finance and Chief Financial Officer of Varian Medical Systems, Inc. Ms. Finney will participate in the non-employee director compensation arrangements described in the Company's 2011 proxy statement. She will receive an annual cash retainer of $50,000 for her service on the board of directors and an annual cash retainer of $12,000 for her service on the audit committee. As a new non-employee director, Ms. Finney will receive a stock option grant of 40,000 shares upon first becoming a director. In connection with the election, the Company entered into an indemnification agreement with Ms. Finney, the terms of which are identical in all material respects to the form of indemnification agreement that the Company has previously entered into with each of its directors, which was filed with the Securities and Exchange Commission as Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended September 26, 2008.
A copy of the press release announcing Ms. Finney's election is included herewith as Exhibit 99.1 and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
99.1 Press Release dated September 14, 2011
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
/s/ Katherine E.Schuelke
Senior Vice President, General Counsel, and Secretary
Dated : September 14, 2011
Exhibit No. Description
Press Release dated September 14, 2011